Malaysia is an important generic drug production base in Southeast Asia, with a mature regulatory system, a complete industrial support framework, and a large number of medical professionals. Many local pharmaceutical enterprises mainly focus on the production of oral solid preparations, and their production capacity continues to grow. Not only do they meet the domestic medical drug demands, but they also supply a large amount of products to ASEAN countries.
As the industry competition becomes increasingly fierce and the official approval standards become stricter, the generic drug factories in Malaysia are constantly updating their production processes and equipment. Reasonable planning of the layout of the oral solid dosage form granulation plant design and the selection of standardized production equipment have become the key to improving product quality stability and enhancing the market competitiveness of pharmaceutical enterprises. This article will introduce the leading generic drug manufacturers in Malaysia, analyze the common production problems of each factory, and provide equipment solutions suitable for the tropical climate of this region.
Top 10 Generic Drug Manufacturers in Malaysia (2026)
Company Profile (including official website link and oral solid dosage form capacity)
The generic drug market in Malaysia is mainly supported by large pharmaceutical companies and medium-sized pharmaceutical factories specializing in specific fields. Local well-known enterprises include Duopharma Biotech, Pharmaniaga Berhad, Kotra Pharma, and Hovid Berhad, etc. Each enterprise mainly produces tablets, capsules, and granules, but their production capacity and market positioning vary significantly.
The industry giants have multiple GMP-certified production workshops, with extremely high annual output of oral solid preparations. In addition to supplying the local market, they also export a large amount of products to the entire ASEAN market. While medium-sized pharmaceutical factories focus more on specific treatment areas, they mainly provide products to local hospitals and chain pharmacies in Malaysia.
All legal pharmaceutical enterprises will publicly disclose production capacity data, qualification certifications, and product information on their websites, so that pharmaceutical factories can upgrade their production lines and choose pharmaceutical wet granulation system as a reference basis.
Common Production Challenges Faced by Generic Drug Plants
Malaysia has a tropical climate, with high temperatures and humidity throughout the year. In addition, the strict auditing standards of NPRA and PIC/S make local generic drug factories face multiple production problems:
The air humidity is too high, which easily causes powder to absorb moisture and deteriorate, resulting in uneven particle size and inconsistent tablet hardness, and unstable product quality.
Pharmaceutical factories have a wide variety of products and frequent changes in formulas, requiring equipment to be able to quickly switch batches and stably adapt to different formula requirements.
The high requirements of official audits for production traceability records and equipment cleaning verification significantly increase the daily compliance and quality control pressure of the factories.
Enterprises also need to control production costs in the long term, and must strike a balance between equipment investment, maintenance costs, and production efficiency.
Core Production Requirements of Malaysian Generic Drug Plants
Process Requirements for Solid Dosage Forms of Generic Drugs
The whole point of generic drug production is nailing consistent bioequivalence, y’know? And particle quality directly affects how well the final med dissolves and its clinical effects. To keep particle size distribution totally consistent and make every batch reproducible, factories gotta use standardized wet granulation and drying processes. A solid, pharmaceutical wet granulation system can cut batch-to-batch variations way down, helping companies breeze through generic drug registration and bioequivalence tests.
Key Considerations for Selecting Pharmaceutical Equipment in Malaysia’s Tropical Environment
Malaysian pharma plants can’t just copy traditional production setups straight up — they’ve gotta adapt to the local tropical climate. Moisture resistance and constant temperature handling performance are super important metrics when screening equipment.
Also, equipment layout needs to fit right in with the design of the oral solid dosage form granulation plant design, and match up with the cleanroom HVAC system and utility layout. Only when you get climate-adapted plant planning and properly matched equipment can you guarantee long-term, stable production of humidity-sensitive generic meds.
Reasons why the JLB series fluidized bed granulation coating machine matches its oral solid dosage production requirements
The JLB Series Fluid Bed Granulator Coater fits Malaysia’s generic production scenarios perfectly. It can precisely control the temp and humidity inside the processing chamber, block out humid external air, and stop particles from absorbing moisture. Its integrated granulation and coating design replaces multiple separate devices, simplifies material transfer steps, and effectively cuts down cross-contamination risks in multi-product production workshops.
JIANPAI JLB Series Fluidized Bed Granulation Coating Machine: Solution for Malaysian Generic Pharmaceutical Factory
Core functions: top spray granulation, bottom spray Wurster micro-pellet coating, side spray granulation
This multi-functional fluid bed device covers three mainstream processing modes, and can meet all kinds of regular production needs:
Top Spray Granulation:Works for granulating standard tablet formulas, perfect for large-scale production of common oral solid dosages.
Bottom Spray Wurster Particle Coating:Uses professional particle coating tech for sustained-release and controlled-release generic meds, optimizes drug release performance.
Side Spray Granulation: Fits multi-layer granulation processes, meets the R&D needs for customized formulas of special generic products.
When paired with a rapid mixing granulator, this device can build a seamless one-stop granulation production flow, and massively boost the continuity of oral solid dosage production.
Compliance Advantage: Meets cGMP standards, optional CIP online cleaning, full documentation support for NPRA, PIC/S audits
As a cGMP pharmaceutical granulation equipment, the JLB series fully satisfies international pharma production regulations. The optional CIP (Clean-in-Place) system takes the place of manual disassembly and cleaning, ramps up cleaning efficiency, and cuts down human operation errors.
This system supports full document output required for NPRA and PIC/S audits, including full-process production records, cleaning validation data, and equipment qualification documents. The complete compliance system totally eases the audit prep pressure on companies’ QA teams.
Process scalability: from small-scale trial, medium-scale trial to mass production model, suitable for generic drug formula research and commercial production
This device covers the whole workflow from small-batch lab testing, pilot trials all the way to large-scale commercial production. Companies can directly transfer mature formula process parameters from small-scale test gear to large production units, no need for repeated adjustments. This awesome scalability totally keeps pace with the R&D iteration and capacity expansion rhythm of generic pharma enterprises.
How should the Malaysian generic drug factory deploy the equipment?
Single machine use, for small batch generic drug formula research and development
This standalone setup is perfect for pharma companies’ R&D labs and pilot production workshops, y’know? It’s super cost-effective too — you can swap out formulas super often and run small trial batches, which totally covers all your generic drug formula screening and stability testing needs, while keeping those initial equipment investment costs totally under control.
Access to the closed-loop oral solid dosage form production line, used for large-scale production of generic tablet and micro-tablet
If a big pharma plant’s got tons of export orders targeting the ASEAN market, we’d totally recommend integrating all the gear into a closed oral solid dosage production line. The whole line uses a vacuum automatic feeding system, so all steps like granulation, drying and coating run fully automatically — no staff even need to touch the materials directly. That cuts down the risk of material exposure and contamination by a ton, and also cranks up the overall efficiency of large-scale batch production big time.
After-sales and validation data support for Southeast Asian customers
Our brand offers one-stop on-site services for all Southeast Asian clients, including equipment installation and commissioning, technical training, and guidance on validation documents. Localized after-sales support cuts equipment downtime to the absolute minimum, helps your workshop staff pick up standardized operation, cleaning and maintenance skills super fast, and makes sure all your gear runs stably for ages.
Conclusion
Malaysia’s generic drug industry’s been growing nonstop, but local pharma manufacturers have always been stuck with two big headaches: disruptions to drug production from the hot, humid tropical climate, and the pressure of strict international regulatory audits.
The JLB series fluid bed granulator coater’s packed with full features, fully cGMP compliant, and supports flexible capacity expansion. No matter if you’re doing R&D for small-batch new drug formulas, or full-on large-scale commercial production of oral solid dosages, it’s gonna perfectly fit the production upgrade needs of Malaysian pharma plants.
This unit can either be used as a standalone device on its own, or slotted into an automated closed production line — it checks every box for Malaysian pharma factories’ production upgrade requirements. If your plant’s currently working on upgrades and capacity expansion, and you need a set of reliable, cGMP pharmaceutical granulation equipmentfor sieving operations, hit us up at JIANPAI for a custom industrial solution. We’d love for you to reach out to our engineering team, and we’ll tailor a dedicated production configuration plan just for you based on your workshop setup and product positioning.
FAQs
Q1: Can fluid bed equipment make Malaysia’s humidity-sensitive generic drugs?
A: Totally no problem at all. This unit is fully enclosed, fitted with a super precise temperature and humidity control system that effectively blocks out humid ambient air, so it fully protects all moisture-sensitive drug powders. Paired with cleanroom environment controls, it’s more than capable of stable production of all kinds of humidity-sensitive generic drugs. The JIANPAI technical team’s got loads of experience optimizing processes for tropical pharma plants in Southeast Asia, so the adaptability is totally tried and tested.
Q2: Can JLB equipment pass NPRA and PIC/S audits, and provide the full set of validation documents?
A: Yep, absolutely. The unit comes with complete IQ, OQ and PQ certification document templates that cover every core material required for official audits. All the company needs to do is finish the site-specific process validation based on their actual workshop conditions, and they’ll fully meet all regulatory standards.
Q3: What’s the difference between top spray and bottom spray modes?
A: The top spray mode is mainly for regular granulation, fits large-scale production of common tablets, and works great for mass production of generic drugs. The bottom spray mode is a specialized micro-powder coating process for extended-release generic drugs, which can optimize the drug release rate and make the medicinal effect last way longer.
Skip to content 
EN 
RU 
KO 
JA 
TR 
ZH 
TH 
PT 
FR 
ES